Literature DB >> 15161078

Trypanosome microtubule-associated protein p15 as a vaccine for the prevention of African sleeping sickness.

Reuven Rasooly1, Naomi Balaban.   

Abstract

Trypanosomes cause African sleeping sickness, affecting millions of humans and animals. We tested trypanosome microtubule-associate protein (MAP p15) as a vaccine in mice, and show that p15 (native or recombinant) generated up to 100% protection from an otherwise lethal challenge of a heterologous strain of Trypanosoma brucei. We also tested the adenovirus as a vaccine delivery system and show that both adenoviral vector containing p15 gene or control adenovirus containing lacZ gene generated a protective response and exhibited strong CD8+ T-cell proliferation. These results suggest that the p15 protein itself is an effective vaccine and that the adenovirus may be used to mount a non-specific cellular immune response.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15161078     DOI: 10.1016/j.vaccine.2003.08.041

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

Review 1.  Host-parasite interactions in trypanosomiasis: on the way to an antidisease strategy.

Authors:  Nicolas Antoine-Moussiaux; Philippe Büscher; Daniel Desmecht
Journal:  Infect Immun       Date:  2009-01-21       Impact factor: 3.441

2.  Analysis of gene expression profiles in the liver and spleen of mice infected with Trypanosoma evansi by using a cDNA microarray.

Authors:  San-Qiang Li; Simon A Reid; Ming-Chiu Fung; Noboru Inoue; Zhao-Rong Lun
Journal:  Parasitol Res       Date:  2008-10-09       Impact factor: 2.289

3.  Immunization with recombinant actin from Trypanosoma evansi induces protective immunity against T. evansi, T. equiperdum and T. b. brucei infection.

Authors:  San-Qiang Li; Wu-Biao Yang; Zhao-Rong Lun; Ling-Jun Ma; Shou-Min Xi; Qun-Li Chen; Xiao-Wei Song; Jian Kang; Lan-Ze Yang
Journal:  Parasitol Res       Date:  2008-10-16       Impact factor: 2.289

Review 4.  Sustainable Elimination (Zero Cases) of Sleeping Sickness: How Far Are We from Achieving This Goal?

Authors:  Pearl Ihuoma Akazue; Godwin U Ebiloma; Olumide Ajibola; Clement Isaac; Kenechukwu Onyekwelu; Charles O Ezeh; Anthonius Anayochukwu Eze
Journal:  Pathogens       Date:  2019-08-29

5.  Modulation of the immunogenicity of the Trypanosoma congolense cysteine protease, congopain, through complexation with alpha(2)-macroglobulin.

Authors:  Laura Elizabeth Joan Huson; Edith Authié; Alain Francçois Boulangé; James Phillip Dean Goldring; Theresa Helen Taillefer Coetzer
Journal:  Vet Res       Date:  2009-06-24       Impact factor: 3.683

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.